{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T04:33:28Z","timestamp":1728534808560},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,9]]},"DOI":"10.7759\/cureus.71158","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T18:21:58Z","timestamp":1728498118000},"source":"Crossref","is-referenced-by-count":0,"title":["Prostatic Adenocarcinoma in a Patient With a History of Cryptorchidism-Associated Hypogonadism: A Case Report"],"prefix":"10.7759","author":[{"given":"Haadia","family":"Safdar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matin","family":"Sheriff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javed","family":"Burki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sher Shah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp MB","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020, 77:38-52. 10.1016\/j.eururo.2019.08.005","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.07.003","article-title":"Androgen receptors in hormone-dependent and castration-resistant prostate cancer","volume":"140","author":"Shafi AA","year":"2013","unstructured":"Shafi AA, Yen AE, Weigel NL. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Pharmacol Ther. 2013, 140:223-38. 10.1016\/j.pharmthera.2013.07.003","journal-title":"Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2006.09.032","article-title":"Prostate cancer risk in testosterone-treated men","volume":"102","author":"Raynaud JP","year":"2006","unstructured":"Raynaud JP. Prostate cancer risk in testosterone-treated men. J Steroid Biochem Mol Biol. 2006, 102:261-6. 10.1016\/j.jsbmb.2006.09.032","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000165166.36280.60","article-title":"Prostate cancer in men using testosterone supplementation","volume":"174","author":"Gaylis FD","year":"2005","unstructured":"Gaylis FD, Lin DW, Ignatoff JM, Amling CL, Tutrone RF, Cosgrove DJ. Prostate cancer in men using testosterone supplementation. J Urol. 2005, 174:534-8. 10.1097\/01.ju.0000165166.36280.60","journal-title":"J Urol"},{"key":"ref5","article-title":"The etiology of benign prostatic hypertrophy","volume":"23","author":"Huggins C","year":"1947","unstructured":"Huggins C. The etiology of benign prostatic hypertrophy. Bull N Y Acad Med. 1947, 23:696-704.","journal-title":"Bull N Y Acad Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0116","article-title":"Characterization of prostate cancer in a functional eunuch","volume":"14","author":"Stocking JJ","year":"2016","unstructured":"Stocking JJ, Fiandalo MV, Pop EA, Wilton JH, Azabdaftari G, Mohler JL. Characterization of prostate cancer in a functional eunuch. J Natl Compr Canc Netw. 2016, 14:1054-60. 10.6004\/jnccn.2016.0116","journal-title":"J Natl Compr Canc Netw"},{"key":"ref7","article-title":"Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism","volume":"15","author":"Marks LS","year":"2006","unstructured":"Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism. JAMA. 2006, 15:2351.","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0715","article-title":"Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy","volume":"14","author":"Parsons JK","year":"2005","unstructured":"Parsons JK, Carter HB, Platz EA, Wright EJ, Landis P, Metter EJ. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiol Biomarkers Prev. 2005, 14:2257-60. 10.1158\/1055-9965.EPI-04-0715","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.07.024","article-title":"Low free testosterone and prostate cancer risk: a collaborative analysis of 20 prospective studies","volume":"74","author":"Watts EL","year":"2018","unstructured":"Watts EL, Appleby PN, Perez-Cornago A, et al.. Low free testosterone and prostate cancer risk: a collaborative analysis of 20 prospective studies. Eur Urol. 2018, 74:585-94. 10.1016\/j.eururo.2018.07.024","journal-title":"Eur Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.06.071","article-title":"Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries","volume":"193","author":"Haider A","year":"2015","unstructured":"Haider A, Zitzmann M, Doros G, Isbarn H, Hammerer P, Yassin A. Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries. J Urol. 2015, 193:80-6. 10.1016\/j.juro.2014.06.071","journal-title":"J Urol"},{"key":"ref11","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress, Paris 2024. (2024). https.\/\/uroweb.org\/guidelines."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff AM","year":"2023","unstructured":"Lincoff AM, Bhasin S, Flevaris P, et al.. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023, 389:107-17. 10.1056\/NEJMoa2215025","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/301889-prostatic-adenocarcinoma-in-a-patient-with-a-history-of-cryptorchidism-associated-hypogonadism-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T18:22:01Z","timestamp":1728498121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/301889-prostatic-adenocarcinoma-in-a-patient-with-a-history-of-cryptorchidism-associated-hypogonadism-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.71158","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,9]]}}}